AEHR’s AI Pivot Drives Record Bookings, But Execution Gap Persists

What happened

Aehr Test Systems has reframed itself as an AI infrastructure play, with AI processors and silicon photonics now generating 91% of revenue. Fourth-quarter bookings surged to a record $60.7 million, lifting effective backlog to approximately $100.6 million, supporting 160–200% FY2027 revenue growth. However, the latest quarter still showed revenue down 44% YoY to $10.3 million and a net loss of $3.2 million, highlighting the gap between orders and shipments. The DeepValue master report maintains a WAIT rating, noting the stock at $115.3 prices a steep ramp without proven shipment cadence or margin improvement. Insider selling clusters and completed ATM equity dilution further cloud the risk/reward.

Implication

The record bookings and AI pivot are positive but insufficient without conversion to revenue. The stock’s valuation ($115.3, P/E -310) leaves no room for error. Key catalysts include Sonoma shipments from the new contract manufacturer and sequential revenue growth in FY27. Risks include customer concentration (Customer A at 42%), cancellable purchase orders, and potential further dilution. Until financials confirm the narrative, the risk/reward is unattractive; attractive entry is $80, trim above $130.

Thesis delta

The narrative has shifted from an EV SiC supplier to an AI burn-in bottleneck, but the fundamental challenge remains: converting record orders into shipments and margins. The bookings surge increases the probability of a successful ramp but does not change the need for execution proof. This raises the bar for upside, as the stock has already rallied on orders without operational validation, making the risk of disappointment higher.